• New Guidelines Aim to Help Doctors Recognize, Manage Side Effects of Immune Checkpoint Inhibitors
  • Incysus Reports Its Drug-Resistant Brain Cancer Immunotherapy Can Be Cold-preserved
  • Imfinzi Is First Immunotherapy Approved for Advanced Non-small Cell Lung Cancer in US
  • Imfinzi Seen to Safely Help Certain Patients with Advanced Head and Neck Cancer in Phase 2 Trial
  • Opdivo Safe for Head and Neck Cancer Patients on Radiation and Chemo, Phase 1 Trial Shows
  • 73% of Kidney Cancer Patients Respond to Inlyta-Keytruda Combo, Trial Shows
  • More Than Half of Urothelial Cancer Patients Benefited from Tislelizumab in a Phase 1 Trial
  • Phase 2 Trial to Evaluate Combo of Imprime PGG, Keytruda in Head and Neck Cancer
  • Targovax Therapy and Chemo Trigger Immune Response to Mesothelioma, Phase 1/2 Trial Shows
  • Tecentriq-Avastin Combo Keeps Advanced Kidney Cancer in Check, Roche Says
  • PD-1 Inhibitors May Help Children with Certain Form of Aggressive Brain Cancer, Study Says
  • Opdivo-Yervoy Combo Delays Disease Progression in Certain Patients with Advanced NSCLC, Study Shows